Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive global trial has found that a combination of two medications, enzalutamide ...
The UK's National Screening Committee has recommended that only a very small group of men at high risk of prostate cancer should be screened for the disease. There is currently no screening programme ...